Augustine S. Lee, M.D.

Closed for Enrollment

• A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Subjects with Idiopathic Pulmonary Fibrosis (IPF) (RAINIER) Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz.

  The purpose of this study is to determine if Simtuzumab (GS-6624) is safe and effective in treating Idiopathic Pulmonary Fibrosis.

• Obstructive Sleep Apnea and Chronic Cough Jacksonville, Fla.

  This study is designed to determine if there is an association between obstructive sleep apnea (OSA) and chronic cough, and if treatment of OSA with CPAP improves chronic cough.

• Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough Jacksonville, Fla.

  This is a mechanistic research study to evaluate the relationship between cough, reflux, and aspiration in patients with systemic sclerosis (scleroderma).